The U.S. Supreme Court gave a victory to patient lawsuits against drugmakers, upholding a $7 million award to a woman who lost her arm after being injected with Wyeth’s Phenergan nausea treatment. The Court, in Wyeth v. Levine, voting 6-3, said patients can use state product liability statutes to bring a case that involves companies failing to provide adequate safety warnings for dangerous drugs. In this case, pharmaceutical makers argued that they were shielded from lawsuits by the Food and Drug Administration’s approval of a treatment and its packaging information. However, the U.S. Supreme Court disagreed.
“Congress did not intend FDA oversight to be the exclusive means of ensuring drug safety and effectiveness,” Justice John Paul Stevens wrote for the court.
The ruling is a defeat for drug companies in a case that might have given them a shield from product liability suits in Arkansas and all other states. Justices Anthony Kennedy, David Souter, Stephen Breyer, Ruth Bader Ginsburg and Clarence Thomas joined Stevens in the majority.